Recently, various executives have taken part in insider selling activity for the stocks of Intercept Pharmaceuticals Inc (NASDAQ:ICPT), Kite Pharma Inc (NASDAQ:KITE), Agios Pharmaceuticals Inc (NASDAQ:AGIO), and Pacira …
Regulatory Viewpoints The market punished Kite Pharma Inc (NASDAQ:KITE)’s shares during the first half of August selling off -30% from the close on …
In a research report issued Monday, Maxim Group analyst Jason McCarthy reiterated a Buy rating on shares of Kite Pharma Inc (NASDAQ:KITE) with a price …
Canaccord analyst John Newman weighed in today with a few insights on Kite Pharma Inc (NASDAQ:KITE), after the company informed investors that there was one …
Tesla Motors Inc (NASDAQ:TSLA) shares are up 4.96% in pre-market trading to $255.
Kite Pharma Inc (NASDAQ:KITE) provided an update from the Company’s ongoing Phase 1/2 clinical trial of KTE-C19 in patients with refractory aggressive non-Hodgkin’s lymphoma …
Canaccord analyst John Newman was out pounding the table on Kite Pharma Inc (NASDAQ:KITE), reiterating a Buy rating and price target of $90, …
Kite Pharma Inc (NASDAQ:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT™) products for the treatment of cancer, today …
Kite Pharma Inc (NASDAQ:KITE) and The Leukemia & Lymphoma Society (LLS) announced that they have entered into a partnership to enhance the development of …
